Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Favorable outcomes including post-transplant survival are seen independent of baseline skin burden in treatment-naïve patients (pts) with blastic plasmacytoid dendritic cell neoplasm (BPDCN) treated with tagraxofusp (TAG): Subgroup analysis of a pivotal Trial

Eunice Wang, Andrew Lane, Anthony Selwyn Stein, Sumithira Vasu, Todd Rosenblat, David Rizzieri, Marina Konopleva, John Katsetos, Alessandra Tosolini, Naveen Pemmaraju

Blood (2025) 146 (Supplement 1): 5221.

https://doi.org/10.1182/blood-2025-5221

Published: 2025

Journal Articles

Longer survival with tagraxofusp versus venetoclax in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): Results of a real-world analysis

Anthony Selwyn Stein, Guru Subramanian Guru Murthy, Pankit Vachhani, Hannah Levavi, Sunil Iyer, Debbie Goldschmidt, Yipeng Gao, John Katsetos, Corey Pelletier, Tibor Kovacsovics

Blood (2025) 146 (Supplement 1): 4612.

https://doi.org/10.1182/blood-2025-4612

Published: 2025

Journal Articles

Application of a Validated Composite Comorbidity Score Measuring Both Fitness and Cytogenetic Risk to Assess Outcomes in 1L AML Patients Who Received Venetoclax Plus Azacitidine in Viale-A

Adriano Venditti, Jing-Zhou Hou, Pierre Fenaux, Brian A. Jonas, Radovan Vrhovac, Pau Montesinos, Jacqueline S. Garcia, David Rizzieri, Michael J. Thirman, Melissa Montez, Yingyi Liu, John Katsetos, Jalaja Potluri, Catherine Miller, Vinod A. Pullarkat

Blood (2022) 140 (Supplement 1): 8993–8995.

https://doi.org/10.1182/blood-2022-158500

Published: 2022